{"summary":"Passionate immunologist, virologist and drug discoverer. 15-y pharma industry experience, directly targeting pathogens or modulating the host, with small & large molecules or gene therapy. Expert knowledge of TLR \/ innate immune modulation and RSV, Influenza, SARS-CoV-2, Hepatitis B & C.\n\nAll aspects from initiating target exploration to supporting phase 2a clinical studies. \n4 NME entering early development.\nManaging multidisciplinary teams of 10+ members.\n27 peer-reviewed publications, oral & poster presentations at EASL 2019 & international conferences.\nReviewer for J Med Chem & ACS Omega.\nMentored 2 post-doctoral, 1 PhD, 5 master students & young scientists.\nFELASA C certificate for in vivo explorations.","lastName":"Herschke, PhD","objectUrn":"urn:li:member:41984653","geoRegion":"Antwerp, Flemish Region, Belgium","fullName":"Florence Herschke, PhD","firstName":"Florence","currentPositions":[{"companyName":"ExeVir","title":"Head of preclinical development","tenureAtCompany":{"numMonths":4},"companyUrnResolutionResult":{"employeeCountRange":"2-10","headquarters":{"geographicArea":"Flemish Region","country":"Belgium","city":"Ghent","postalCode":"9052","line1":"Technologiepark Zwijnaarde 94"},"website":"http:\/\/www.exevir.com","flagshipCompanyUrl":"https:\/\/www.linkedin.com\/company\/exevir\/","industry":"Biotechnology"},"startedOn":{"month":2,"year":2024},"companyUrn":"urn:li:fs_salesCompany:66756940"}],"entityUrn":"urn:li:fs_salesProfile:(ACwAAAKAoo0BfCvuAn7snZu4tSY16d0CXRQK99U,NAME_SEARCH,kmSD)","profilePictureDisplayImage":{"artifacts":[{"width":100,"fileIdentifyingUrlPathSegment":"100_100\/0\/1704751881372?e=1723075200&v=beta&t=5D-RgPJyD_2KLISq6IjeFiOLZqNIBX7jHMuJJ1nrVCA","height":100},{"width":200,"fileIdentifyingUrlPathSegment":"200_200\/0\/1704751881372?e=1723075200&v=beta&t=iDMW3G11j4l6vSLbIvyPiwDXFpfGrXXiVKfBP9KwEw8","height":200},{"width":389,"fileIdentifyingUrlPathSegment":"400_400\/0\/1704751881372?e=1723075200&v=beta&t=2wcKeE3U-fjh2qsP36viU-a1hCCog2ZgS_5IXYCHsrE","height":389},{"width":389,"fileIdentifyingUrlPathSegment":"800_800\/0\/1704751881372?e=1723075200&v=beta&t=yhIBM7CEuZFrscMZbaPIP_UhemqIUkLJdVy71KvrVUU","height":389}],"rootUrl":"https:\/\/media.licdn.com\/dms\/image\/D4D03AQG7Dz3bg9N0gQ\/profile-displayphoto-shrink_"},"projects":[],"contactInfo":{},"industry":"Pharmaceutical Manufacturing","educations":[{"endedOn":{"year":2007},"degree":"PhD","eduId":30777923,"fieldsOfStudy":["Virology, Innate immunity"],"schoolName":"University of Lyon","startedOn":{"year":2004}},{"endedOn":{"year":2004},"degree":"Bachelor+Master","eduId":30778320,"schoolUrn":"urn:li:fs_salesSchool:1102489","school":"urn:li:fs_salesSchool:1102489","fieldsOfStudy":["Biology"],"schoolName":"\u00c9cole normale sup\u00e9rieure Paris-Saclay","startedOn":{"year":2000}},{"endedOn":{"year":2000},"degree":"classe pr\u00e9pa, highly competitive Bachelor preparation","eduId":30778322,"fieldsOfStudy":["biology (BCPST)"],"schoolName":"Lyc\u00e9e du Parc","startedOn":{"year":1997}},{"schoolName":"Lyc\u00e9e Stendhal - Ecole fran\u00e7aise de Milan","eduId":56985196}],"skills":[{"numOfEndorsement":0,"name":"Small Molecules"},{"numOfEndorsement":0,"name":"Large molecules"},{"numOfEndorsement":0,"name":"Gene Therapy"},{"numOfEndorsement":2,"name":"Pharmaceutical Industry"},{"numOfEndorsement":3,"name":"Life Sciences"},{"numOfEndorsement":2,"name":"Biotechnology"},{"numOfEndorsement":6,"name":"Drug Discovery"},{"numOfEndorsement":0,"name":"Early clinical development"},{"numOfEndorsement":0,"name":"Pharmacology"},{"numOfEndorsement":0,"name":"Inflammatory diseases"},{"numOfEndorsement":6,"name":"Infectious Diseases"},{"numOfEndorsement":1,"name":"Cell Biology"},{"numOfEndorsement":2,"name":"Molecular Biology"},{"numOfEndorsement":3,"name":"Animal Models"},{"numOfEndorsement":3,"name":"In Vivo"},{"numOfEndorsement":13,"name":"Immunology"},{"numOfEndorsement":0,"name":"Microbiology"},{"numOfEndorsement":2,"name":"Virology"},{"numOfEndorsement":4,"name":"Hepatitis B"},{"numOfEndorsement":4,"name":"Biochemistry"},{"numOfEndorsement":0,"name":"High Throughput Screening"}],"numOfConnections":1184,"patents":[],"headline":"Head of preclinical development @ ExeVir","courses":[],"certifications":[],"memberBadges":{"premium":false,"openLink":false,"jobSeeker":false},"flagshipProfileUrl":"https:\/\/www.linkedin.com\/in\/florence-herschke-phd-81108812","organizations":[],"location":"Antwerp, Flemish Region, Belgium","publications":[],"positions":null,"posts":[{"createdAt":1717225800000,"insightId":"354456d9-ceed-41a1-8b72-caf3cb2e6a35","activityUnion":{"postActivity":{"contentSummaryUnion":{"ingestedContentSummary":{"image":{"attributes":[{"originalImageUrl":"https:\/\/media.licdn.com\/dms\/image\/sync\/D4D27AQG09kRcV9SAJA\/articleshare-shrink_800\/0\/1716130762350?e=1717977600&v=beta&t=wQyvYUkmTJQ1pLK5ETc6ytgKdYPhLuRuY6OOcV4WMXU","sourceType":"URL","imageUrl":"https:\/\/media.licdn.com\/dms\/image\/sync\/D4D27AQG09kRcV9SAJA\/articleshare-shrink_800\/0\/1716130762350?e=1717977600&v=beta&t=wQyvYUkmTJQ1pLK5ETc6ytgKdYPhLuRuY6OOcV4WMXU"}]},"description":"Respiratory syncytial virus (RSV) can cause pulmonary complications in infants, elderly and immunocompromised patients. While two vaccines and two pro\u2026","resolvedUrl":"https:\/\/authors.elsevier.com\/a\/1jBDObqnSRR2D","title":"JNJ-7184, a respiratory syncytial virus inhibitor targeting the connector domain of the viral polymerase"}},"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":33},{"type":"PRAISE","count":5}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:activity:7202567255098884096","threadUrn":"urn:li:activity:7202567255098884096","reactionsCount":38,"commentsCount":0,"canComment":true},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:share:7202567254385795072","message":{"attributes":[{"start":140,"length":24,"value":{"com.linkedin.common.HyperlinkAttributedEntity":{"url":"https:\/\/lnkd.in\/eshVsnDN"}}}],"text":"Delighted to share our latest article on JNJ-7184. While good prophylactic options for RSV are now available, treatment ones remain scarce:\nhttps:\/\/lnkd.in\/eshVsnDN\n\nHeartfelt thanks to all co-authors, in particular to my ex-JNJ team, Peter Rigaux, Dirk Roymans, Anil Koul, Brecht Bonneux... for this long journey !"},"entityUrn":"urn:li:share:7202567254385795072"}}},{"createdAt":1714422060000,"insightId":"0fb67065-5b49-4331-97bd-ca44f198d91f","activityUnion":{"postActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":1}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:activity:7190807397064470528","threadUrn":"urn:li:activity:7190807397064470528","reactionsCount":1,"commentsCount":0,"canComment":true},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:share:7190807396590481408","message":{"attributes":[],"text":"Great opportunity!"},"rootActivity":{"contentSummaryUnion":{"referenceContentSummary":{"entityUrn":"urn:li:job:3903365106"}},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:share:7190623869471260672","message":{"attributes":[],"text":"\ud83c\udf86 Great opportunity in a fantastic team! Come join us, and\/or feel free to forward\/share within your network!"},"entityUrn":"urn:li:share:7190623869471260672"},"entityUrn":"urn:li:share:7190807396590481408"}}},{"createdAt":1716962940000,"insightId":"407781d1-9acc-4e87-98e9-cf311ff62a1d","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":1}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7201316463691841536,7201464592852496385)","threadUrn":"urn:li:ugcPost:7201316463691841536","reactionsCount":1,"commentsCount":0,"canComment":true},"commentary":{"attributes":[],"text":"Congratulations Tine !!!"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7201316463691841536"}}},{"createdAt":1714122960000,"insightId":"e836e3d4-050b-4797-9757-3f19923afa54","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7189545552714326017,7189552821497683971)","threadUrn":"urn:li:ugcPost:7189545552714326017","reactionsCount":0,"commentsCount":1,"canComment":true},"commentary":{"attributes":[],"text":"\ud83d\ude02 Happy Retirement Geert !"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7189545552714326017"}}},{"createdAt":1714108200000,"insightId":"6cb9fa8d-7c25-49c1-8aea-fca109977ada","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7189314001044934657,7189490976015495168)","threadUrn":"urn:li:ugcPost:7189314001044934657","reactionsCount":0,"commentsCount":0,"canComment":true},"commentary":{"attributes":[],"text":"F\u00e9licitations Genevi\u00e8ve !"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7189314001044934657"}}},{"createdAt":1711998060000,"insightId":"d2bbb047-38c3-4b61-9ea0-e95477592c9d","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":1}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(activity:7180637477924225024,7180640526214275072)","threadUrn":"urn:li:activity:7180637477924225024","reactionsCount":1,"commentsCount":0,"canComment":true},"commentary":{"attributes":[],"text":"Congratulations Dave !"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:activity:7180637477924225024"}}},{"createdAt":1711560840000,"insightId":"9472f7f3-7618-4d0d-9f01-a0e2a528bfa6","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":3}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(activity:7177976473083916288,7178806575145377792)","threadUrn":"urn:li:activity:7177976473083916288","reactionsCount":3,"commentsCount":1,"canComment":true},"commentary":{"attributes":[],"text":"La tuberculose : oui, \u00e7a m'int\u00e9resse, et pourtant je suis blanche... mais chercheuse \ud83d\ude09 !\nBravo pour ce podcast !"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:activity:7177976473083916288"}}},{"createdAt":1711284840000,"insightId":"a0c318d2-de04-4393-ba4d-c33df568a852","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7177016166563880960,7177649050941304834)","threadUrn":"urn:li:ugcPost:7177016166563880960","reactionsCount":0,"commentsCount":0,"canComment":true},"commentary":{"attributes":[],"text":"F\u00e9licitations Pascale !"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7177016166563880960"}}},{"createdAt":1709675340000,"insightId":"0ac474d3-8288-45d4-bf97-e8bea5d0d5ec","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(activity:7170350421994156032,7170898259685683200)","threadUrn":"urn:li:activity:7170350421994156032","reactionsCount":0,"commentsCount":0,"canComment":true},"commentary":{"attributes":[],"text":"Fantastic news !"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:activity:7170350421994156032"}}},{"createdAt":1709675160000,"insightId":"045734ce-a130-4b27-aed6-1bcd4b219a5f","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7170494613600858114,7170897464495951873)","threadUrn":"urn:li:ugcPost:7170494613600858114","reactionsCount":0,"commentsCount":0,"canComment":true},"commentary":{"attributes":[],"text":"Fantastic news ! Congratulations Annemieke !"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7170494613600858114"}}},{"createdAt":1709673660000,"insightId":"4424c8a5-8c74-485b-9bcf-01a133c114a3","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7170856257149464578,7170891159295242240)","threadUrn":"urn:li:ugcPost:7170856257149464578","reactionsCount":0,"commentsCount":0,"canComment":true},"commentary":{"attributes":[],"text":"Awesome news !"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7170856257149464578"}}}]}